ArticleMolecular therapy. Nucleic acids2023

Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis.

Priyanka Mohapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.